Feedback / Questions
Omisirge (omidubicel) - Ayrmid
https://www.businesswire.com/news/home/20251216305612/en/RoslinCT-and-Ayrmid-Ltd.-Announce-Expansion-of-Strategic-Partnership-to-Manufacture-Omisirge-omidubicel-onlv-for-Second-FDA-Approved-Indication-in-Severe-Aplastic-Anemia-SAA
Dec 16, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next